Akari Therapeutics
Quarterly Financials
| Values in thousands | 2024-06-30 | 2024-03-31 |
|---|---|---|
Revenue | $0 | $0 |
Gross Profit | -12 | |
EBITDA | -5,555 | -5,976 |
EBIT | -5,988 | |
Net Income | -7,558 | -5,566 |
Net Change In Cash | 0 | 0 |
Free Cash Flow | -4,894 | -4,043 |
Cash | 4,176 | 1,310 |
Basic Shares | 9,418 | 6,726 |
Annual Financials
| Values in thousands | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|
Revenue | $0 | $0 | $0 |
Gross Profit | -3 | -4 | -8 |
EBITDA | -28,520 | -17,016 | -20,651 |
EBIT | -28,523 | -17,020 | -20,659 |
Net Income | -6,972 | -17,606 | -17,597 |
Net Change In Cash | 0 | 0 | 0 |
Free Cash Flow | -21,504 | -18,846 | -16,951 |
Cash | 13,249 | 9,361 | 14,056 |
Basic Shares | 3,121 | 2,146 | 1,579 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-06-30 | -$0.80 |
2024-03-31 | -$0.82 |
2023-09-30 | $0 |
2023-06-30 | $0 |
